omegapharm nystatin oral drops nystatin 100,000iu/ml suspension bottle
cipla australia pty ltd - nystatin, quantity: 100000 iu/ml - oral liquid - excipient ingredients: sodium hydroxide; carmellose sodium; saccharin sodium; sucrose; methyl hydroxybenzoate; sodium citrate dihydrate; purified water; propyl hydroxybenzoate; flavour - for the treatment of oral candidal infections only
breakyl 1200 mcg
megapharm ltd - fentanyl as citrate - buccal film - fentanyl as citrate 1200 mcg - fentanyl - breakyl is indicated for the treatment of breakthrough pain (btp) in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.btp is a transitory exacerbation of pain that occurs on a background of otherwise controlled persistent pain.
breakyl 200 mcg
megapharm ltd - fentanyl as citrate - buccal film - fentanyl as citrate 200 mcg - fentanyl - breakyl is indicated for the treatment of breakthrough pain (btp) in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.btp is a transitory exacerbation of pain that occurs on a background of otherwise controlled persistent pain.
breakyl 400 mcg
megapharm ltd - fentanyl as citrate - buccal film - fentanyl as citrate 400 mcg - fentanyl - breakyl is indicated for the treatment of breakthrough pain (btp) in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.btp is a transitory exacerbation of pain that occurs on a background of otherwise controlled persistent pain.
breakyl 600 mcg
megapharm ltd - fentanyl as citrate - buccal film - fentanyl as citrate 600 mcg - fentanyl - breakyl is indicated for the treatment of breakthrough pain (btp) in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.btp is a transitory exacerbation of pain that occurs on a background of otherwise controlled persistent pain.
breakyl 800 mcg
megapharm ltd - fentanyl as citrate - buccal film - fentanyl as citrate 800 mcg - fentanyl - breakyl is indicated for the treatment of breakthrough pain (btp) in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.btp is a transitory exacerbation of pain that occurs on a background of otherwise controlled persistent pain.
spark-gap orthopaedic extracorporeal shock wave therapy system
physikal health services pty ltd - 47789 - spark-gap orthopaedic extracorporeal shock wave therapy system - is based on shock wave therapy method and is intended to apply shockwaves on body tissue for the treatment of selected medical conditions such as : chronic pain, tendinosiscalcarea and osteorestoration.
influvac
viatris limited - influenza virus a/michigan/45/2015 (h1n1) pdm09 - like strain 15ug (a/singapore/gp1908/2015, ivr-180); influenza virus a/singapore/infimh-16-0019/2016 (h3n2) - like strain 15ug (a/singapore/infimh-16-0019/2016, nib-104); influenza virus b/phuket/3073/2013 - like strain 15ug (b/phuket/3073/2013, wild type) - suspension for injection - 0.5 ml - active: influenza virus a/michigan/45/2015 (h1n1) pdm09 - like strain 15ug (a/singapore/gp1908/2015, ivr-180) influenza virus a/singapore/infimh-16-0019/2016 (h3n2) - like strain 15ug (a/singapore/infimh-16-0019/2016, nib-104) influenza virus b/phuket/3073/2013 - like strain 15ug (b/phuket/3073/2013, wild type) excipient: calcium chloride dihydrate dibasic sodium phosphate dihydrate magnesium chloride hexahydrate monobasic potassium phosphate potassium chloride sodium chloride water for injection - for the prevention of influenza virus, types a and b in adults and children older than 6 months in accordance with the recommendations in the national immunisation guideline.
orfadin 2 mg hard capsules
megapharm ltd - nitisinone - hard capsule - nitisinone 2 mg - nitisinone - nitisinone - treatment of patients with confirmed diagnosis of hereditary tyrosinemia type 1 (ht-1) in combination with dietary restriction of tyrosine and phenylalanine05/06/2018 בקשה לשינוי משטר מינון once daily
orfadin 5 mg hard capsules
megapharm ltd - nitisinone - hard capsule - nitisinone 5 mg - nitisinone - nitisinone - treatment of patients with confirmed diagnosis of hereditary tyrosinemia type 1 (ht-1) in combination with dietary restriction of tyrosine and phenylalanine05/06/2018 בקשה לשינוי משטר מינון once daily